162 related articles for article (PubMed ID: 7954448)
1. Loss of heterozygosity in familial tumors from three BRCA1-linked kindreds.
Neuhausen SL; Marshall CJ
Cancer Res; 1994 Dec; 54(23):6069-72. PubMed ID: 7954448
[TBL] [Abstract][Full Text] [Related]
2. A 400 kb novel deletion unit centromeric to the BRCA1 gene in sporadic epithelial ovarian cancer.
Tangir J; Muto MG; Berkowitz RS; Welch WR; Bell DA; Mok SC
Oncogene; 1996 Feb; 12(4):735-40. PubMed ID: 8632895
[TBL] [Abstract][Full Text] [Related]
3. Germline BRCA1 mutations and loss of the wild-type allele in tumors from families with early onset breast and ovarian cancer.
Merajver SD; Frank TS; Xu J; Pham TM; Calzone KA; Bennett-Baker P; Chamberlain J; Boyd J; Garber JE; Collins FS
Clin Cancer Res; 1995 May; 1(5):539-44. PubMed ID: 9816013
[TBL] [Abstract][Full Text] [Related]
4. Somatic and germline mutations of the BRCA2 gene in sporadic ovarian cancer.
Foster KA; Harrington P; Kerr J; Russell P; DiCioccio RA; Scott IV; Jacobs I; Chenevix-Trench G; Ponder BA; Gayther SA
Cancer Res; 1996 Aug; 56(16):3622-5. PubMed ID: 8705994
[TBL] [Abstract][Full Text] [Related]
5. Mutations of the BRCA1 gene in human cancer.
Xu CF; Solomon E
Semin Cancer Biol; 1996 Feb; 7(1):33-40. PubMed ID: 8695765
[TBL] [Abstract][Full Text] [Related]
6. Consistent loss of the wild type allele in breast cancers from a family linked to the BRCA2 gene on chromosome 13q12-13.
Collins N; McManus R; Wooster R; Mangion J; Seal S; Lakhani SR; Ormiston W; Daly PA; Ford D; Easton DF
Oncogene; 1995 Apr; 10(8):1673-5. PubMed ID: 7731724
[TBL] [Abstract][Full Text] [Related]
7. Different tumor types from BRCA2 carriers show wild-type chromosome deletions on 13q12-q13.
Gudmundsson J; Johannesdottir G; Bergthorsson JT; Arason A; Ingvarsson S; Egilsson V; Barkardottir RB
Cancer Res; 1995 Nov; 55(21):4830-2. PubMed ID: 7585515
[TBL] [Abstract][Full Text] [Related]
8. Characterization of familial non-BRCA1/2 breast tumors by loss of heterozygosity and immunophenotyping.
Oldenburg RA; Kroeze-Jansema K; Meijers-Heijboer H; van Asperen CJ; Hoogerbrugge N; van Leeuwen I; Vasen HF; Cleton-Jansen AM; Kraan J; Houwing-Duistermaat JJ; Morreau H; Cornelisse CJ; Devilee P
Clin Cancer Res; 2006 Mar; 12(6):1693-700. PubMed ID: 16551851
[TBL] [Abstract][Full Text] [Related]
9. The Brca1 and Brca2 proteins and tumor pathogenesis.
Ingvarsson S
Anticancer Res; 1999; 19(4B):2853-61. PubMed ID: 10652564
[TBL] [Abstract][Full Text] [Related]
10. Novel somatic mutations in the BRCA1 gene in sporadic breast tumors.
Janatova M; Zikan M; Dundr P; Matous B; Pohlreich P
Hum Mutat; 2005 Mar; 25(3):319. PubMed ID: 15712267
[TBL] [Abstract][Full Text] [Related]
11. A deletion unit on chromosome 17q in epithelial ovarian tumors distal to the familial breast/ovarian cancer locus.
Jacobs IJ; Smith SA; Wiseman RW; Futreal PA; Harrington T; Osborne RJ; Leech V; Molyneux A; Berchuck A; Ponder BA
Cancer Res; 1993 Mar; 53(6):1218-21. PubMed ID: 8095178
[TBL] [Abstract][Full Text] [Related]
12. Localization of potential tumor suppressor loci to a < 2 Mb region on chromosome 17q in human prostate cancer.
Gao X; Zacharek A; Grignon DJ; Sakr W; Powell IJ; Porter AT; Honn KV
Oncogene; 1995 Oct; 11(7):1241-7. PubMed ID: 7478543
[TBL] [Abstract][Full Text] [Related]
13. Detection of germline BRCA1 mutations in breast cancer patients by quantitative messenger RNA in situ hybridization.
Kainu T; Kononen J; Johansson O; Olsson H; Borg A ; Isola J
Cancer Res; 1996 Jul; 56(13):2912-5. PubMed ID: 8674039
[TBL] [Abstract][Full Text] [Related]
14. Detailed genetic and physical mapping of tumor suppressor loci on chromosome 3p in ovarian cancer.
Fullwood P; Marchini S; Rader JS; Martinez A; Macartney D; Broggini M; Morelli C; Barbanti-Brodano G; Maher ER; Latif F
Cancer Res; 1999 Sep; 59(18):4662-7. PubMed ID: 10493522
[TBL] [Abstract][Full Text] [Related]
15. Altered expression and loss of heterozygosity of the LOT1 gene in ovarian cancer.
Cvetkovic D; Pisarcik D; Lee C; Hamilton TC; Abdollahi A
Gynecol Oncol; 2004 Dec; 95(3):449-55. PubMed ID: 15581945
[TBL] [Abstract][Full Text] [Related]
16. Double heterozygosity for mutations in the BRCA1 and BRCA2 genes in a breast cancer patient.
Tsongalis GJ; Linfert DR; Johnson RC; Ackroyd R; Berman MM; Ricci A
Arch Pathol Lab Med; 1998 Jun; 122(6):548-50. PubMed ID: 9625424
[TBL] [Abstract][Full Text] [Related]
17. Genetic analysis of eight breast-ovarian cancer families with suspected BRCA1 mutations.
Couch FJ; Garber J; Kiousis S; Calzone K; Hauser ER; Merajver SD; Frank TS; Boehnke M; Chamberlain JS; Collins FS
J Natl Cancer Inst Monogr; 1995; (17):9-14. PubMed ID: 8573462
[TBL] [Abstract][Full Text] [Related]
18. BRCA2 mutations in primary breast and ovarian cancers.
Lancaster JM; Wooster R; Mangion J; Phelan CM; Cochran C; Gumbs C; Seal S; Barfoot R; Collins N; Bignell G; Patel S; Hamoudi R; Larsson C; Wiseman RW; Berchuck A; Iglehart JD; Marks JR; Ashworth A; Stratton MR; Futreal PA
Nat Genet; 1996 Jun; 13(2):238-40. PubMed ID: 8640235
[TBL] [Abstract][Full Text] [Related]
19. The search for BRCA1.
Friedman LS; Ostermeyer EA; Lynch ED; Szabo CI; Anderson LA; Dowd P; Lee MK; Rowell SE; Boyd J; King MC
Cancer Res; 1994 Dec; 54(24):6374-82. PubMed ID: 7987831
[TBL] [Abstract][Full Text] [Related]
20. Loss of heterozygosity in normal breast epithelial tissue and benign breast lesions in BRCA1/2 carriers with breast cancer.
Cavalli LR; Singh B; Isaacs C; Dickson RB; Haddad BR
Cancer Genet Cytogenet; 2004 Feb; 149(1):38-43. PubMed ID: 15104281
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
